Chemical Structure (Eplerenone 01)
Eplerenone Tablet, Coated
Product Images NDC 71205-863
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Eplerenone (NDC 71205-863). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Eplerenone 02)
Figure 2 (Eplerenone 03)
Figure 3 (Eplerenone 04)
Figure 4 (Eplerenone 05)
71205-863-30 (Eplerenone 06)
Eplerenone 25mg is a prescription drug that comes in a round, beige, biconvex film-coated tablet debossed with "25" on one side. The tablets are packaged in a bottle of 30 and contain 25 mg of eplerenone each. The product is manufactured by Bluepharma Indústria Farmacêutica S.A. and has a product ID of QE086330. The medication should be stored at 25°C (77°F) and kept out of reach of children. The package is produced by Rofcent Rx LP in Thousand Oaks, CA 91320 and has a GTIN number of 0371205863302. The expiration date and lot number are not available.*
71205-864-30 (Eplerenone 07)
Eplerenone is a prescription medication indicated as a treatment for high blood pressure and heart failure. This particular product has the formulation of 50mg strength, comes in a package of 30 beige, round, biconvex firm-coated tablets, each debossed with *50" on one side. The product is manufactured by Bluepharma Industria Farmaceutica in Coimbra, Portugal, and packaged by Profcent Rx LP in Thousand Oaks, CA. It has the NDC code of 71205-864-30 and GTIN code of 0371205864309. However, the expiration date and lot number information are not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
